R

Regeneron Ventures portfolio

Regeneron Ventures has 5 portfolio companies on record at Recent Funding, with 3 investments in the last 12 months. It led 2 of the 7 rounds it joined. Its most recent investment on record is City Therapeutics's $99.5M Series B+ round in June 2026, alongside Viking Global Investors, Sofinnova Investments, Slate Path Capital and 6 others. By category, its portfolio leans toward Health and bio (5) and Logistics and mobility (1). It has co-invested with Fidelity, ARCH Venture Partners and Invus, most often Fidelity (2 rounds).

What Regeneron Ventures invests in

• Health and bio · 5 · 100%
• Logistics and mobility · 1 · 20%

Regeneron Ventures recent investments

Company	Round	Date	Alongside
CCity Therapeutics	Series B+ · $99.5M	Jun 8, 2026	Viking Global Investors (lead), Sofinnova Investments (lead), Slate Path Capital +6
AAtavistik Bio	Series B+ · $40M	Mar 5, 2026	The Column Group, RA Capital Management (lead), Nextech Invest +1
AAtavistik Bio	Series B+ · $120M	Dec 18, 2025	The Column Group (lead), Nextech Invest (lead), Lux Capital
AActio Biosciences	Series B+ · $66M · lead	Jun 18, 2025	Euclidean Capital, Droia Ventures, Deerfield (lead) +1
NNormunity	Series B+ · $75M	Jan 13, 2025	YK Bioventures, Taiho Ventures, Sanofi Ventures +6
TTune Therapeutics	Series B+ · $175M · lead	Jan 12, 2025	Yosemite (lead), NEA (lead), Hevolution Foundation (lead)
CCity Therapeutics	Series A · $135M	Oct 8, 2024	Slate Path Capital, Rock Springs Capital, Invus +3

How Regeneron Ventures invests

Share is of the 7 rounds on Recent Funding that name Regeneron Ventures. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Regeneron Ventures portfolio companies

• CCity Therapeutics$99.5MSeries B+ · Jun 2026
• AAtavistik Bio$40MSeries B+ · Mar 2026
• AActio Biosciences$66MSeries B+ · Jun 2025
• NNormunity$75MSeries B+ · Jan 2025
• TTune Therapeutics$175MSeries B+ · Jan 2025

Company	Round with Regeneron Ventures	Total raised	Latest raise
CCity Therapeutics Health and bio	Jun 8, 2026 Series B+ · $99.5M	$234.5M	Jun 8, 2026 Series B+
AAtavistik Bio Health and bio	Mar 5, 2026 Series B+ · $40M	$220M	Mar 5, 2026 Series B+
AActio Biosciences Health and bio	Jun 18, 2025 Series B+ · $66M · lead	$121M	Jun 18, 2025 Series B+
NNormunity Health and bio	Jan 13, 2025 Series B+ · $75M	$140M	Jan 13, 2025 Series B+
TTune Therapeutics Health and bio	Jan 12, 2025 Series B+ · $175M · lead	$215M	Jan 12, 2025 Series B+

Most frequent co-investors

• FFidelity2 shared rounds · last Jun 8, 2026
• AARCH Venture Partners2 shared rounds · last Jun 8, 2026
• IInvus2 shared rounds · last Jun 8, 2026
• SSlate Path Capital2 shared rounds · last Jun 8, 2026
• RRock Springs Capital2 shared rounds · last Jun 8, 2026
• LLux Capital2 shared rounds · last Mar 5, 2026
• TThe Column Group2 shared rounds · last Mar 5, 2026
• NNextech Invest2 shared rounds · last Mar 5, 2026
• VViking Global Investors1 shared round · last Jun 8, 2026
• SSofinnova Investments1 shared round · last Jun 8, 2026
• NNYBC Ventures1 shared round · last Jun 8, 2026
• CCasdin Capital1 shared round · last Jun 8, 2026

Similar investors

• DDecheng Capital5 companies · 3 deals in 12 mo
• MMaverick Ventures5 companies · 3 deals in 12 mo
• TThe Venture Collective5 companies · 3 deals in 12 mo
• AAtlas Venture5 companies · 2 deals in 12 mo
• DDigitalis Ventures5 companies · 2 deals in 12 mo
• FFlare Capital Partners5 companies · 2 deals in 12 mo

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

Portfolio companies are the companies on Recent Funding with a round that lists Regeneron Ventures, which is a subset of its real portfolio. API: /api/v1/investors/regeneron-ventures (get a free API key). More: the most active VC firms and new venture capital funds.